Merck & Company (MRK) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58933Y1055

Cancer, Vaccines, Diabetes, Veterinary, Pharmaceuticals

Merck & Co., Inc. is a leading healthcare company that operates globally, focused on improving lives through innovative medicines and solutions.

The company's Pharmaceutical segment is dedicated to developing and providing a wide range of human health products, including life-saving medicines for various therapeutic areas such as oncology, immunology, neuroscience, and virology. Some of its well-known brands include Keytruda, Bridion, Adempas, and Januvia, among others. Additionally, the company offers a comprehensive portfolio of vaccines for pediatric, adolescent, and adult populations, including Gardasil, ProQuad, and M-M-R II, to name a few.

The Animal Health segment is committed to advancing the health and well-being of animals through its innovative veterinary pharmaceuticals, vaccines, and health management solutions. The company's products and services cater to various stakeholders, including veterinarians, animal producers, farmers, and pet owners. Its digitally connected identification, traceability, and monitoring products further enhance the care and management of animals.

Merck & Co., Inc. serves a diverse customer base, including drug wholesalers and retailers, hospitals, government agencies, managed health care providers, physicians, and distributors. The company has established strategic partnerships with other industry leaders, such as Daiichi Sankyo, AstraZeneca PLC, Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, to co-develop and co-commercialize innovative treatments for various diseases and conditions.

With a rich history dating back to 1891, Merck & Co., Inc. is headquartered in Rahway, New Jersey, and continues to drive innovation and progress in the healthcare industry. For more information, please visit

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Merck & Company (MRK) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Merck & Company (MRK) - Stock Price & Dividends

MRK Stock Overview

Market Cap in USD 330,962m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1978-01-13

MRK Stock Ratings

Growth 5y 66.3
Fundamental -15.9
Dividend 7.63
Rel. Performance vs Sector 0.69
Analysts 4.46/5
Fair Price Momentum 127.07 USD
Fair Price DCF 87.31 USD

MRK Dividends

Yield 12m 2.38%
Yield on Cost 5y 4.38%
Dividends CAGR 5y 6.55%
Payout Consistency 97.8%

MRK Growth Ratios

Growth 12m 18.75%
Growth Correlation 12m 51%
Growth Correlation 3m 30%
CAGR 5y 12.93%
CAGR/Mean DD 5y 1.77
Sharpe Ratio 12m 0.78
Alpha vs SP500 12m 3.93
Beta vs SP500 5y weekly 0.45
ValueRay RSI 33.49
Volatility GJR Garch 1y 14.60%
Price / SMA 50 -0.26%
Price / SMA 200 10.44%
Current Volume 8518.7k
Average Volume 20d 7731.9k

External Links for MRK Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of MRK stocks?
As of June 18, 2024, the stock is trading at USD 127.50 with a total of 8,518,700 shares traded.
Over the past week, the price has changed by -2.45%, over one month by -2.23%, over three months by +5.62% and over the past year by +19.74%.
What are the forecast for MRK stock price target?
According to ValueRays Forecast Model, MRK Merck & Company will be worth about 139.1 in June 2025. The stock is currently trading at 127.50. This means that the stock has a potential upside of +9.11%.
Issuer Forecast Upside
Wallstreet Target Price 143 12.1
Analysts Target Price 117.2 -8.08
ValueRay Target Price 139.1 9.11

The Journey of Merck & Company Inc: From Humble Beginnings to Global Pharma Leader

History of Merck & Company Inc

Founded in 1891 by George Merck in the United States, Merck & Company Inc, known outside the U.S. and Canada as MSD, has a storied history that spans more than a century. Originating from a small chemical company, it has evolved into one of the world's leading pharmaceutical and healthcare giants. The journey of Merck is marked by its dedication to research and development (R&D), leading to breakthroughs in medicines and vaccines across a broad range of diseases.

Core Business

At the heart of Merck & Company Inc's operations is its commitment to improving health worldwide. The core business focuses on pharmaceutical products, including a wide array of prescription medicines and vaccines. Merck is renowned for its contributions to oncology, infectious diseases, cardiology, and diabetes among others. With a robust R&D department, Merck continuously works on developing new treatments and therapies to address unmet medical needs.

Side Businesses

Besides its primary pharmaceutical ventures, Merck & Company Inc has diversified its business into other areas, enhancing its portfolio and market reach. This includes animal health products, which offer a range of veterinary medicines and vaccines. The company also engages in the development and promotion of biopharmaceutical solutions through strategic collaborations and acquisitions, thus supporting various healthcare needs beyond human medications.

Current Market Status

As of the latest reports, Merck & Company Inc remains a formidable player in the pharmaceutical industry with a strong global presence. It continues to experience growth, thanks in part to its innovative product pipeline and strategic market initiatives. The company has been resilient in navigating challenges, including competitive pressures and global health crises, by leveraging its R&D strengths and adapting to changing market dynamics. Merck's commitment to health care innovation and its ability to address the needs of patients and healthcare providers worldwide solidify its status as a leading pharmaceutical company.